scholarly journals Complete Resection and Adjuvant Radiation Yield Improved Local Control in Patients With Recurrent Pleomorphic Adenoma

Author(s):  
S.E. Nicholas ◽  
L. Vujaskovic ◽  
R. DeLuna ◽  
J. Bishop ◽  
C. Fakhry ◽  
...  
2021 ◽  
pp. 739-745
Author(s):  
Zane Blank ◽  
Richard Sleightholm ◽  
Beth Neilsen ◽  
Michael Baine ◽  
Chi Lin

Juvenile nasopharyngeal angiofibroma (JNA) is a relatively uncommon, benign neoplasm of the nasopharynx that can be very difficult to diagnose early due to inconspicuous and seemingly harmless presenting symptoms. Early diagnosis and treatment of JNA are essential for a good prognosis. JNA typically responds well to radiation therapy (RT), but when it does not, the most appropriate next course of action has not been readily defined due to the limited occurrence and experience with this neoplasm. Herein, we describe a JNA patient, who continued to progress after surgery and 36 Gy of adjuvant radiation, but after an additional 14.4 Gy, he has remained in remission for over 2 years. An 11-year-old boy who presented with JNA underwent treatment with embolization and surgical resection. Unfortunately, the tumor progressed within 2 months of surgical intervention and he required RT for adequate local control. While undergoing RT, he again demonstrated signs of progression; so his radiation regimen was increased from 3,600 cGy in 20 fractions to 5,040 cGy in 28 fractions. Since completing RT, the tumor has continued to decrease in size, and the patient is stable and has been without signs of disease progression for over 24 months now. Thus, escalating the radiation regimen to 5,040 cGy may improve local control in rapidly progressive JNA.


2020 ◽  
Vol 2020 ◽  
pp. 1-18
Author(s):  
Mohammed AlKindi ◽  
Sundar Ramalingam ◽  
Lujain Abdulmajeed Hakeem ◽  
Manal A. AlSheddi

Salivary gland tumors (SGT) comprise 3% of all head and neck tumors, are mostly benign, and arise frequently in the parotid gland. Pleomorphic adenoma (PA) is the commonest SGT, representing 60-70% of all benign parotid tumors. Clinically, parotid PA presents as irregular, lobulated, asymptomatic, slow-growing preauricular mass, involving both superficial and deep lobes, and could grow to gigantic proportions. Histologically, PA has epithelial and mesenchymal elements in chondromyxoid matrix and is managed surgically. Based on a review of 43 cases reported in English literature since 1995, giant parotid PA is reported as large as 35 cm (diameter) and 7.3 kg (resected weight). Although rare, 10 cases of malignant transformation were reported in the review. Surgical management included extracapsular dissection (ECD), superficial parotidectomy, and total parotidectomy for benign tumors, and adjuvant radiation or chemotherapy for malignant tumors. We further present the case of a 36-year-old healthy male with slow-growing and asymptomatic giant parotid PA, of 4-year duration. The patient presented with firm, lobulated preauricular swelling, provisionally diagnosed as PA based on radiographic and cytological findings. The tumor was resected through ECD, and the patient had uneventful postoperative recovery and a 7-year recurrence-free follow-up period. Histological examination revealed epimyoepithelial proliferation punctuated by chondromyxoid areas, with extensive squamous metaplasia and keratin cysts. To the best of knowledge from indexed literature, giant parotid PA is rarely reported in Saudi Arabia. In addition to its rarity, this case is reported for its benign nature despite atypical histological presentation, successful surgical management without complications, and long-term recurrence-free follow-up. Based on this report, clinicians must be aware of atypical histological presentations associated with PA and plan suitable surgical management and follow-up to avoid morbidity. Nevertheless, attempts must be made to diagnose and manage these lesions at an early stage and before they reach gigantic proportions.


2021 ◽  
pp. 1-6
Author(s):  
Justin M. Hintze ◽  
Fergal O’Duffy ◽  
Ailbhe White-Gibson ◽  
Paul O’Neill ◽  
John Kinsella ◽  
...  

2014 ◽  
Vol 151 (1) ◽  
pp. 87-91 ◽  
Author(s):  
Huawei Liu ◽  
Weisheng Wen ◽  
Haitao Huang ◽  
Yongqiang Liang ◽  
Xinying Tan ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Saman Vegari ◽  
Masoud Naderpour ◽  
Alireza Hemmati ◽  
Hosein Baybordi

Introduction. Although pleomorphic adenoma is the most common neoplasm of the salivary glands, this tumor most commonly involves the minor salivary glands of palatal and rarely occurs in cervical region.Case Report. A 21-year-old female referred to our clinic due to painless mass of right upper region of neck. After paraclinical and pathologic evaluation, it was diagnosed as cervical pleomorphic adenoma.Conclusion. Pleomorphic adenoma may be rarely involving the neck. Although the prognosis is good, the choice treatment is the complete resection of the tumor.


This chapter discusses the etiology, clinical presentation, assessment, and treatment of recurrent pleomorphic adenoma. Recurrent tumor following surgery (or any other treatment) usually presents as a recurrent swelling at the primary site, with or without local symptoms. The incidence of recurrence following surgery varies depending on surgical technique, surgeon's experience, duration of follow-up, and clinical integrity. A recurrence rate of less than 1% is generally considered acceptable. The best policy to prevent recurrence of pleopmorphic adenoma is excisional biopsy of the tumor with maximal safe margin and functional neurological preservation. Treatment is determined by the age and physical health of the patient, number of pervious operations, and anatomical extent of the recurrence. Treatment options include observation, local excision, superficial parotidectomy, total conservative parotidectomy, total parotidectomy with resection of the involved nerve and immediate nerve graft (any procedure is followed by radiotherapy), and radiotherapy alone.


Sign in / Sign up

Export Citation Format

Share Document